首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Feasibility of spinal cord stimulation in angina pectoris in patients with chronic pacemaker treatment for cardiac arrhythmias.
【24h】

Feasibility of spinal cord stimulation in angina pectoris in patients with chronic pacemaker treatment for cardiac arrhythmias.

机译:慢性心律失常的慢性起搏器治疗患者在心绞痛中使用脊髓刺激的可行性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Spinal cord stimulation (SCS) has been used since 1985 as additional symptom-relieving treatment for patients with severe angina pectoris despite optimal conventional medical and invasive treatment. SCS has antiischemic effects and is safe and effective in long-term use. Several patients with coronary artery disease also suffer from disorders that necessitate the use of a cardiac permanent pacemaker (PPM). The combination of SCS and PPM has previously been considered hazardous because of possible false inhibition of the PPM. To assess if thoracic SCS and PPM can be safely combined in patients with refractory angina pectoris, 18 patients treated with both SCS and PPM were tested. The PPM settings were temporarily modified to increase the probability of interference, while the SCS intensity (used in bipolar mode) was increased to the maximum level tolerated by the patient. Any sign of inhibition of the ventricular pacing was recorded by continuous ECG monitoring. With the aid of a questionnaire, symptomsof interference during long-term treatment were evaluated. No patient had signs of inhibition during the tests. Reprogramming of the pacemaker because of the test results was not needed in any of the patients. The long-term follow-up data revealed no serious events. This study indicates that bipolar SCS and PPM can be safely combined in patients with refractory angina pectoris. However, individual testing is mandatory to ascertain safety in each patient. A testing procedure for patients in need of SCS and PPM is suggested in this article.
机译:自1985年以来,尽管采用了最佳的常规药物和侵入性治疗方法,脊髓刺激(SCS)仍被用作重度心绞痛患者的其他症状缓解治疗。 SCS具有抗缺血作用,并且长期使用安全有效。数名患有冠状动脉疾病的患者还患有必须使用心脏永久起搏器(PPM)的疾病。 SCS和PPM的组合以前被认为是危险的,因为可能会错误地抑制PPM。为了评估难治性心绞痛患者是否可以安全合并胸腔SCS和PPM,对18例同时接受SCS和PPM治疗的患者进行了测试。临时修改了PPM设置以增加干扰的可能性,同时将SCS强度(用于双极模式)增加到患者可以承受的最大水平。通过连续的ECG监测记录了任何心室起搏抑制迹象。借助问卷调查,评估了长期治疗期间的干扰症状。在测试期间,没有患者有抑制的迹象。在任何患者中,都不需要因为测试结果而对起搏器进行重新编程。长期随访数据未发现严重事件。这项研究表明,难治性心绞痛患者可以安全地合并双相SCS和PPM。但是,必须进行单独测试才能确定每位患者的安全性。本文建议了一种针对需要SCS和PPM的患者的测试程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号